SCHEMBL24319009

SCHEMBL24319009

c1cc(-c2ccoc2-c2ccncc2)ccn1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 5/20 0.79
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
TSHR P16473 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
DYRK1A Q13627 1/20 0.41
PTK2 Q05397 1/20 0.39
TP53 P04637 1/20 0.38
PKM P14618 1/20 0.38
NOTUM Q6P988 1/20 0.37
PABPC1 P11940 1/20 0.35
APOBEC3A P31941 1/20 0.35
EIF4H Q15056 1/20 0.35
APOBEC3G Q9HC16 1/20 0.35
PIK3R1 P27986 1/20 0.35
PIK3CA P42336 1/20 0.35
MAPK13 O15264 2/20 0.34
MAPK12 P53778 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8133757 0.89 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11
SCHEMBL887941 0.76 CHRM2 (0.50) MAPK14MEN1KMT2ACYP3A4CYP2A6
SCHEMBL12892528 0.76 SMN1; SMN2 (0.62) MAPK14LMNAMAPTTSHRSMN1; SMN2
SCHEMBL5106019 0.76 MAPK14 (0.55) MAPK14LMNAMAPTTSHRSMN1; SMN2
SCHEMBL5410034 0.74 MAPK14 (0.51) MAPK14CYP1A2
SCHEMBL10950612 0.73 MAPK14 (0.79) MAPK14SMN1; SMN2NOTUMPIK3R1PIK3CA
SCHEMBL27999101 0.73 CHRM2 (0.53) MAPK14LMNAMAPTSMN1; SMN2MEN1
SCHEMBL1257344 0.72 ALDH1A1 (0.49) MAPK14LMNAMAPTSMN1; SMN2MEN1
SCHEMBL24318703 0.71 CYP2A6 (0.52) MAPK14LMNAMAPTSMN1; SMN2DYRK1A
SCHEMBL5634176 0.70 MAPK14 (0.49) MAPK14LMNAMAPTTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220098217-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE LT MATERIALS CO., LTD. (KR) 2022-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220098217-A1 COMPOUND, ORGANIC OPTOELECTRONIC ELEMENT, AND DISPLAY DEVICE AOX1, OXER1, OR51E2 MAPK14 773/4885LMNA 4800/4885MAPT 2875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.